Glenmede Trust Company »

Kura Oncology shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $272k 13k 21.33

More positions owned by Glenmede Trust Company

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Small Cp Etf (VB)
Home Depot (HD)
Procter & Gamble Company (PG)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Glenmede Trust Company

Top funds holding Kura Oncology

Suvretta Capital Management
BlackRock
EcoR1 Capital
Deerfield Management Company
BVF
Vanguard Group
Paradigm Biocapital Advisors
venBio Select Advisor
Holocene Advisors
Armistice Capital
Artal Group
Foresite Capital Management IV
Geode Capital Management
Franklin Resources
Commodore Capital

View all funds holding Kura Oncology